OraLabs Files Preliminary Proxy

OraLabs Holding Corp. (Nasdaq:OLAB) announced today that
yesterday it filed a Preliminary Proxy Statement with the United
States Securities and Exchange Commission that contains a complete
statement of the proposed transactions to be undertaken in accordance
with the provisions of the previously disclosed Stock Exchange
Agreement, as amended, with Partner Success Holdings Limited. The
contents of the Preliminary Proxy Statement and the terms of the
transactions may change prior to the filing of a Definitive Proxy
Statement. Closing of the transactions remains subject to numerous
conditions and there is no assurance that a Definitive Proxy Statement
will be filed or that closing of the transactions will occur.

   OraLabs, Inc. manufactures Ice Drops(R) brands oral care products;
Sour Zone(TM) brands sour products; and Lip Rageous(R), Lip
Naturals(R), Chap Ice(R), Extra Lip Moisturizer, Leashables(R),
Chapgrip(R) and Soothe & Shine(R) brands of lip balm. The product line
includes breath drops and sprays, sour drops and sprays, lip balms and
a variety of private label products. The Company distributes
Sanell(TM) hand sanitizer and Eyelieve(TM) sterile eye products. The
Company's products are currently sold in the USA nationally as well as
numerous foreign countries. The products are sold through wholesale
distributors as well as by direct sale to mass retailers, grocery
stores, convenience stores and drug stores.

   Forward-Looking and Cautionary Statements

   Except for historical information and discussions contained
herein, statements included in this release may constitute
"forward-looking statements" within the meaning of the Private
Securities Litigation Reform Act of 1995. Reference is made in
particular to statements regarding anticipated sales growth,
expectations regarding financial results for the quarter and
expectations regarding future outcomes. These statements are based on
the Company's current beliefs and expectations as to such future
outcomes. These statements involve a number of risks, uncertainties,
and other factors that could cause results to differ materially, as
discussed in the Company's filings with the Securities and Exchange
Commission.